US FDA seeks spying suit dismissal
This article was originally published in Clinica
Executive Summary
The US Food and Drug Administration has asked the District Court for the District of Columbia to dismiss a lawsuit brought by former and current agency employees who are asserting their bosses illegally spied on them when they contacted members of Congress about medical devices the scientists argued were not-ready-for-primetime but were permitted entrance into the US market nonetheless, despite safety concerns. The spying allegations first surfaced in August (www.clinica.co.uk, 1 August 2012).